An Open-Label Phase 2 Study to Evaluate Pt2977 for the Treatment Of Von Hippel-Lindau Disease-Associated Renal Cell Carcinoma

Disease:

VHL - Von Hippel-Lindau Syndrome, VHL Gene Mutation, VHL Syndrome, VHL Gene Inactivation, VHL-Associated Renal Cell Carcinoma, VHL-Associated Clear Cell Renal Cell Carcinoma

Study phase:

Phase II

Physician name:

Eric Jonasch

Department:

Genitourinary Medical Oncology

For general questions about clinical trials:

1-888-356-1897